ArticleFrontiers in endocrinology2025

Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study.

Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.